Address : 215 BIRCHWOOD AVE CRANFORD, NJ, 07016-0540 UNITED STATES | |||
Status : H | Type : A | Woman Owned : N | Business Type : N |
Business Size : E | Primary Business : J | CAO Code : S3101A | ADP Code : HQ0337 |
Manufacturer: Schering Plough Corporation |
Part Number | Item Name | NSN | QTY | RFQ |
---|---|---|---|---|
NDC00085-0787-06 | potassium chloride extended release tablets usp | 6505-01-318-5737 | Avl | RFQ |
NDC00085-0806-01 | theophylline extend | 6505-01-272-5114 | Avl | RFQ |
NDC00085-3320-35 | nitroglycerin transdermal system | 6505-01-357-5372 | Avl | RFQ |
NDC00085-0510-06 | betamethasone dipropionate ointment usp | 6505-01-035-6358 | Avl | RFQ |
NDC00085-0566-05 | betamethasone sodiu | 6505-00-904-2190 | Avl | RFQ |
NDC00085-0337-03 | gentamicin sulfate | 6505-01-234-4446 | Avl | RFQ |
NDC00085-0517-01 | betamethasone dipropionate cream usp | 6505-01-269-6737 | Avl | RFQ |
NDC00085-1132-01 | albuterol sulfate i | 6505-01-538-2871 | Avl | RFQ |
NDC00085-0096-01 | vitamin a and vitam | 6505-00-064-0990 | Avl | RFQ |
NDC00085-3320-30 | nitroglycerin trans | 6505-01-237-5373 | Avl | RFQ |
NDC00085-0567-01 | mometasone furoate | 6505-01-270-5963 | Avl | RFQ |
NDC00085-0438-06 | labetalol hydrochloride tablets usp | 6505-01-319-5118 | Avl | RFQ |
K-DUR 10 | potassium chloride extended release tablets usp | 6505-01-280-3014 | Avl | RFQ |
NDC00085-0819-35 | nitroglycerin transdermal system | 6505-01-396-1314 | Avl | RFQ |
NDC00085-1236-03 | ribavirin and interferon combination pack | 6505-01-497-7883 | Avl | RFQ |
NDC00085-0571-02 | interferon alpha 2b recombinant for injection | 6505-01-246-3792 | Avl | RFQ |
NDC00085-0487-01 | theophylline extend | 6505-01-037-5613 | Avl | RFQ |
NDC00085-0362-08 | labetalol hydrochlo | 6505-01-285-0171 | Avl | RFQ |
NDC00085-3320-35 | nitroglycerin trans | 6505-01-157-9064 | Avl | RFQ |
NDC00085-1777-01 | ciprofloxacin oral | 6505-01-492-8089 | Avl | RFQ |
NDC00085-0787-81 | potassium chloride | 6505-01-266-8634 | Avl | RFQ |
NDC00085-0720-04 | perphenazine and am | 6505-01-028-1189 | Avl | RFQ |
NDC11523-7160-08 | loratadine tablets | 6505-01-524-9179 | Avl | RFQ |
NDC00085-1179-02 | interferon alpha 2b recombinant for injection | 6505-01-366-7515 | Avl | RFQ |
NDC00085-0151-05 | gentamicin sulfate | 6505-00-432-1065 | Avl | RFQ |
NDC00085-0567-02 | mometasone furoate | 6505-01-269-6728 | Avl | RFQ |
NDC00085-3320-30 | nitroglycerin trans | 6505-01-157-9064 | Avl | RFQ |
NDC00085-0363-02 | perphenazine oral solution usp | 6505-01-272-2379 | Avl | RFQ |
NDC00085-0370-02 | mometasone furoate | 6505-01-269-6727 | Avl | RFQ |
NDC00085-0517-04 | betamethasone dipro | 6505-01-269-6738 | Avl | RFQ |
NDC11523-7160-02 | loratadine tablets | 6505-01-505-0915 | Avl | RFQ |
NDC00085-0525-05 | flutamide capsules | 6505-01-317-0302 | Avl | RFQ |
NDC00085-0285-02 | interferon alpha 2b recombinant for injection | 6505-01-246-3793 | Avl | RFQ |
NDC00085-0819-30 | nitroglycerin transdermal system | 6505-01-409-2737 | Avl | RFQ |
NDC00085-0571-06 | interferon alpha 2b recombinant for injection | 6505-01-366-7515 | Avl | RFQ |
NDC00085-0077-05 | perphenazine tablet | 6505-01-271-7666 | Avl | RFQ |
8564621 | lidocaine hydrochlo | 6505-01-554-7880 | Avl | RFQ |
CLARITIN ALLERGY 24 HOUR | loratadine tablets | 6505-01-505-0915 | Avl | RFQ |
NDC00085-1737-01 | moxifloxacin hydroc | 6505-01-503-7443 | Avl | RFQ |
NDC00085-1133-01 | interferon alpha 2b recombinant injection | 6505-01-377-1460 | Avl | RFQ |
NDC00085-0263-81 | potassium chloride | 6505-01-284-9218 | Avl | RFQ |
NDC00085-0259-02 | beclomethasone dipr | 6505-01-275-4812 | Avl | RFQ |
NDC00085-3330-35 | nitroglycerin transdermal system | 6505-01-357-5371 | Avl | RFQ |
NDC00085-0458-05 | loratadine tablets | 6505-01-377-1461 | Avl | RFQ |
NDC00085-4110-01 | isosorbide mononitrateextended release tablets | 6505-01-383-7339 | Avl | RFQ |
NDC00085-0705-04 | perphenazine tablets usp | 6505-01-217-1242 | Avl | RFQ |
NDC00085-0296-05 | fluphenazine hydroc | 6505-00-904-2182 | Avl | RFQ |
NDC00085-0244-05 | labetalol hydrochlo | 6505-01-218-7437 | Avl | RFQ |
NDC00085-0933-01 | theophylline extend | 6505-01-083-6613 | Avl | RFQ |
NDC00085-0525-03 | flutamide capsules usp | 6505-01-329-6495 | Avl | RFQ |
NDC00085-0614-02 | albuterol inhalatio | 6505-01-116-9245 | Avl | RFQ |
NDC00085-0525-06 | flutamide capsules usp | 6505-01-377-1443 | Avl | RFQ |
NDC00085-0525-04 | flutamide capsules | 6505-01-306-1728 | Avl | RFQ |
NDC00085-0584-01 | theophylline extend | 6505-01-037-5607 | Avl | RFQ |
NDC00085-4110-03 | isosorbide mononitrate extended release tablets | 6505-01-388-2487 | Avl | RFQ |
NDC00085-0096-05 | vitamin a and vitam | 6505-01-141-0826 | Avl | RFQ |
REBETRON 600 | ribavirin and interferon combination pack | 6505-01-497-7883 | Avl | RFQ |
NDC00085-0787-01 | potassium chloride | 6505-01-266-8634 | Avl | RFQ |
NDC00085-0691-02 | ceftibuten capsules | 6505-01-435-9294 | Avl | RFQ |
NDC00085-0263-01 | potassium chloride extended release tablets usp | 6505-01-280-3014 | Avl | RFQ |
NDC00085-3305-35 | nitroglycerin transdermal system | 6505-01-357-5370 | Avl | RFQ |
NDC00085-0362-06 | labetalol hydrochlo | 6505-01-257-9990 | Avl | RFQ |
NDC00085-0244-08 | labetalol hydrochloride tablets usp | 6505-01-218-7436 | Avl | RFQ |
NDC00085-0370-01 | mometasone furoate | 6505-01-269-6729 | Avl | RFQ |
NDC00085-0647-05 | interferon alpha 2b recombinant for injection | 6505-01-349-3539 | Avl | RFQ |
NDC00085-0510-04 | betamethasone dipro | 6505-01-034-3651 | Avl | RFQ |
NDC00085-3315-35 | nitroglycerin trans | 6505-01-357-5373 | Avl | RFQ |
NDC00085-0539-01 | interferon alpha 2b recombinant for injection | 6505-01-351-9262 | Avl | RFQ |
NDC00085-0728-01 | betamethasone dipro | 6505-01-233-1901 | Avl | RFQ |
NDC00085-0752-07 | labetalol hydrochloride tablets usp | 6505-01-319-6667 | Avl | RFQ |
NDC00085-0598-04 | perphenazine and amitriptyline hydrochloride table | 6505-01-342-9196 | Avl | RFQ |
NDC00085-0074-05 | sulfacetamide sodium and prednisolone acetate opht | 6505-01-149-3562 | Avl | RFQ |
NDC00085-0598-08 | perphenazine and am | 6505-01-299-9141 | Avl | RFQ |
NDC00085-0002-03 | betamethasone valerate lotion usp | 6505-00-515-8638 | Avl | RFQ |
00085-4110-03 | isosorbide mononitrate extended release tablets | 6505-01-388-2487 | Avl | RFQ |
ETRAFON 4 25 | perphenazine and am | 6505-01-296-3183 | Avl | RFQ |
NDC00085-0438-03 | labetalol hydrochlo | 6505-01-197-4180 | Avl | RFQ |
NDC00085-0720-08 | perphenazine and am | 6505-01-296-3183 | Avl | RFQ |
NDC00085-0752-08 | labetalol hydrochloride tablets usp | 6505-01-319-5117 | Avl | RFQ |
NDC00085-0362-09 | labetalol hydrochloride injection usp | 6505-01-319-5119 | Avl | RFQ |
ETRAFON 2-25 | perphenazine and amitriptyline hydrochloride table | 6505-01-342-9196 | Avl | RFQ |
INTRON A PAK 10 | interferon alpha 2b recombinant for injection | 6505-01-366-7515 | Avl | RFQ |
NDC00085-0819-35 | nitroglycerin transdermal system | 6505-01-409-2737 | Avl | RFQ |
NDC00085-0933-10 | theophylline extend | 6505-01-070-0821 | Avl | RFQ |
NDC00085-0475-06 | betamethasone dipro | 6505-01-163-4131 | Avl | RFQ |
NDC00085-0444-05 | tolnaftate powder u | 6505-01-037-6536 | Avl | RFQ |
NDC00085-0120-02 | interferon alpha 2b | 6505-01-246-3791 | Avl | RFQ |
NDC00085-0201-05 | diazoxide injection | 6505-00-334-4478 | Avl | RFQ |
NDC00085-0584-81 | theophylline extend | 6505-01-073-1552 | Avl | RFQ |
INTRON A PAK-3 | interferon alpha 2b recombinant for injection | 6505-01-349-3539 | Avl | RFQ |
NDC00085-0924-02 | clotrimazole and be | 6505-01-243-5901 | Avl | RFQ |
![]() |
AS9120B and ISO 9001:2015 |
![]() |
Aviation Suppliers Association Member |
![]() |
FAA AC 0056B Accredited |
![]() |
AS 6081:2012 Certification |
![]() |
ESD S20.20-2014 Certification |